Lipitor/Diabetes Cases Have Reached 'Critical Mass,' Plaintiffs Again Seek MDL

Lipitor/Diabetes Cases Have Reached 'Critical Mass,' Plaintiffs Again Seek MDL

WASHINGTON, D.C. - Two months after the Judicial Panel on Multidistrict Litigation denied her motion to centralize federal lawsuits alleging that the Lipitor cholesterol drug causes diabetes in women, a plaintiff on Oct. 10 again moved for a multidistrict litigation, saying that the growth of the cases to 62 in multiple courts with multiple plaintiffs' counsel has now created a "critical mass" (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2502, JPMDL).

Find full version on lexis Advance®
Access this news story on lexis.com®